OVATF
Price
$0.02
Change
-$0.02 (-50.00%)
Updated
Aug 26 closing price
Capitalization
1.27M
RGEDF
Price
$27.17
Change
+$2.26 (+9.07%)
Updated
Jul 19 closing price
Capitalization
5.62B
Interact to see
Advertisement

OVATF vs RGEDF

Header iconOVATF vs RGEDF Comparison
Open Charts OVATF vs RGEDFBanner chart's image
Ovation Science
Price$0.02
Change-$0.02 (-50.00%)
Volume$500
Capitalization1.27M
Gedeon Richter
Price$27.17
Change+$2.26 (+9.07%)
Volume$3
Capitalization5.62B
OVATF vs RGEDF Comparison Chart in %
Loading...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OVATF vs. RGEDF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OVATF is a Hold and RGEDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (OVATF: $0.02 vs. RGEDF: $27.17)
Brand notoriety: OVATF and RGEDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OVATF: 6% vs. RGEDF: 100%
Market capitalization -- OVATF: $1.27M vs. RGEDF: $5.62B
OVATF [@Pharmaceuticals: Generic] is valued at $1.27M. RGEDF’s [@Pharmaceuticals: Generic] market capitalization is $5.62B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OVATF’s FA Score shows that 0 FA rating(s) are green whileRGEDF’s FA Score has 1 green FA rating(s).

  • OVATF’s FA Score: 0 green, 5 red.
  • RGEDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEDF is a better buy in the long-term than OVATF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OVATF’s TA Score shows that 0 TA indicator(s) are bullish.

  • OVATF’s TA Score: 0 bullish, 2 bearish.

Price Growth

OVATF (@Pharmaceuticals: Generic) experienced а -40.91% price change this week, while RGEDF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.08%. For the same industry, the average monthly price growth was +11.48%, and the average quarterly price growth was +89.39%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEDF($5.62B) has a higher market cap than OVATF($1.27M). RGEDF YTD gains are higher at: 0.000 vs. OVATF (-38.250). RGEDF has higher annual earnings (EBITDA): 335B vs. OVATF (-339.46K). RGEDF has more cash in the bank: 150B vs. OVATF (10.2K). OVATF has less debt than RGEDF: OVATF (284K) vs RGEDF (21.6B). RGEDF has higher revenues than OVATF: RGEDF (903B) vs OVATF (90.3K).
OVATFRGEDFOVATF / RGEDF
Capitalization1.27M5.62B0%
EBITDA-339.46K335B-0%
Gain YTD-38.2500.000-
P/E RatioN/A7.99-
Revenue90.3K903B0%
Total Cash10.2K150B0%
Total Debt284K21.6B0%
FUNDAMENTALS RATINGS
OVATF vs RGEDF: Fundamental Ratings
OVATF
RGEDF
OUTLOOK RATING
1..100
9935
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
10047
PRICE GROWTH RATING
1..100
9570
P/E GROWTH RATING
1..100
10087
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGEDF's Valuation (3) in the null industry is somewhat better than the same rating for OVATF (64). This means that RGEDF’s stock grew somewhat faster than OVATF’s over the last 12 months.

RGEDF's Profit vs Risk Rating (74) in the null industry is in the same range as OVATF (100). This means that RGEDF’s stock grew similarly to OVATF’s over the last 12 months.

RGEDF's SMR Rating (47) in the null industry is somewhat better than the same rating for OVATF (100). This means that RGEDF’s stock grew somewhat faster than OVATF’s over the last 12 months.

RGEDF's Price Growth Rating (70) in the null industry is in the same range as OVATF (95). This means that RGEDF’s stock grew similarly to OVATF’s over the last 12 months.

RGEDF's P/E Growth Rating (87) in the null industry is in the same range as OVATF (100). This means that RGEDF’s stock grew similarly to OVATF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OVATFRGEDF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
55%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
24%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
20%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWMEX65.350.16
+0.25%
American Funds Washington Mutual R4
ISIVX18.710.04
+0.21%
Voya US Stock Index Port A
JSVUX28.83N/A
N/A
JPMorgan Small Cap Value R6
COHOX13.12N/A
N/A
Coho Relative Value Equity
ELCRX42.55N/A
N/A
Eaton Vance Growth R

OVATF and

Correlation & Price change

A.I.dvisor tells us that OVATF and KKPCF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OVATF and KKPCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVATF
1D Price
Change %
OVATF100%
N/A
KKPCF - OVATF
24%
Poorly correlated
N/A
KHTRF - OVATF
24%
Poorly correlated
N/A
NPPNY - OVATF
10%
Poorly correlated
N/A
RGEDF - OVATF
6%
Poorly correlated
N/A
PCLOF - OVATF
4%
Poorly correlated
+35.33%
More

RGEDF and

Correlation & Price change

A.I.dvisor tells us that RGEDF and YCBD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGEDF and YCBD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEDF
1D Price
Change %
RGEDF100%
N/A
YCBD - RGEDF
28%
Poorly correlated
-2.11%
OMID - RGEDF
6%
Poorly correlated
-22.81%
OVATF - RGEDF
6%
Poorly correlated
N/A
PCLOF - RGEDF
5%
Poorly correlated
+35.33%
OWPC - RGEDF
4%
Poorly correlated
+14.72%
More